TRIPP MATTHEW L has a total of 22 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are MACGREGOR ALEXANDER, MERCK HDAC RES LLC and METHYLATION SCIENCES INTERNAT SRL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 18 | |
#2 | Canada | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Tripp Matthew L | 22 |
#2 | Bland Jeffrey S | 18 |
#3 | Babish John G | 18 |
#4 | Liska Deann J | 10 |
#5 | Lukaczer Daniel O | 10 |
#6 | Lerman Robert | 10 |
#7 | Howell Terrence | 9 |
#8 | Darland Gary K | 9 |
#9 | Konda Veera | 7 |
#10 | Hall Amy J | 6 |
Publication | Filing date | Title |
---|---|---|
CA2941096A1 | Phosphodiesterase-4 inhibiting phytochemical compositions | |
US2007184133A1 | Compositions that treat or inhibit pathological conditions associated with inflammatory response | |
US2007281045A1 | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes | |
US2009087512A1 | Encapsulated fractions isolated or derived from hops | |
US8142819B2 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |